Supernus Pharmaceuticals, Inc. ( SUPN) - Key Metrics
SUPN Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $3.69 | -$0.07 | $0.83 | $0.80 |
| 2025Q3 | $3.41 | -$0.80 | -$1.09 | -$1.10 |
| 2025Q2 | $2.95 | $0.40 | $1.04 | $1.04 |
| 2025Q1 | $2.68 | -$0.21 | $0.55 | $0.54 |
SUPN Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -173.57 |
| 2025Q3 | ? | -14.93 |
| 2025Q2 | ? | 19.62 |
| 2025Q1 | ? | -38.67 |
SUPN Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | 2.23% | ? |
| 2025Q4 | 0.68% | ? |
| 2025Q3 | -2.29% | ? |
| 2025Q2 | 3.29% | ? |
| 2025Q1 | 1.65% | ? |
SUPN
Price: $47.07
52 week price:
Earnings Per Share: -0.51 USD
Exchange: NGM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 524852
Ebitda: 27.4 millionMarket Capitalization: 2.8 billion